# Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)

> **NCT06901687** · PHASE2 · RECRUITING · sponsor: **NYU Langone Health** · enrollment: 170 (estimated)

## Conditions studied

- Multiple Sclerosis
- Depression

## Interventions

- **DEVICE:** Active tDCS
- **DEVICE:** Sham tDCS

## Key facts

- **NCT ID:** NCT06901687
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-11
- **Primary completion:** 2028-01-01
- **Final completion:** 2028-06-01
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2025-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06901687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06901687, "Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06901687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*